{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:46:50Z","timestamp":1792522010273,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T00:00:00Z","timestamp":1465171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/ni.3457","type":"journal-article","created":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T13:33:24Z","timestamp":1465220004000},"page":"914-921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":559,"title":["Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS"],"prefix":"10.1038","volume":"17","author":[{"given":"Yong Hwan","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geryl","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jin","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,6]]},"reference":[{"key":"BFni3457_CR1","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner, D.L., Aksentijevich, I. & Goldbach-Mansky, R. Autoinflammatory disease reloaded: a clinical perspective. Cell 140, 784\u2013790 (2010).","journal-title":"Cell"},{"key":"BFni3457_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","volume":"27","author":"SL Masters","year":"2009","unstructured":"Masters, S.L., Simon, A., Aksentijevich, I. & Kastner, D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27, 621\u2013668 (2009).","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"BFni3457_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","volume":"90","author":"The International FMF Consortium","year":"1997","unstructured":"The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90, 797\u2013807 (1997).","journal-title":"Cell"},{"key":"BFni3457_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/9696","volume":"22","author":"JP Drenth","year":"1999","unstructured":"Drenth, J.P. et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat. Genet. 22, 178\u2013181 (1999).","journal-title":"Nat. Genet."},{"key":"BFni3457_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.immuni.2011.02.020","volume":"34","author":"JJ Chae","year":"2011","unstructured":"Chae, J.J. et al. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1\u03b2 activation and severe autoinflammation in mice. Immunity 34, 755\u2013768 (2011).","journal-title":"Immunity"},{"key":"BFni3457_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13449","volume":"513","author":"H Xu","year":"2014","unstructured":"Xu, H. et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513, 237\u2013241 (2014).","journal-title":"Nature"},{"key":"BFni3457_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.abb.2010.09.028","volume":"505","author":"HM Miziorko","year":"2011","unstructured":"Miziorko, H.M. Enzymes of the mevalonate pathway of isoprenoid biosynthesis. Arch. Biochem. Biophys. 505, 131\u2013143 (2011).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFni3457_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","volume":"43","author":"E Sohar","year":"1967","unstructured":"Sohar, E., Gafni, J., Pras, M. & Heller, H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am. J. Med. 43, 227\u2013253 (1967).","journal-title":"Am. J. Med."},{"key":"BFni3457_CR9","doi-asserted-by":"crossref","unstructured":"French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat. Genet. 17, 25\u201331 (1997).","DOI":"10.1038\/ng0997-25"},{"key":"BFni3457_CR10","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/rheumatology\/kei279","volume":"45","author":"HJ Lachmann","year":"2006","unstructured":"Lachmann, H.J. et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology 45, 746\u2013750 (2006).","journal-title":"Rheumatology"},{"key":"BFni3457_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/art.24569","volume":"60","author":"MG Booty","year":"2009","unstructured":"Booty, M.G. et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum. 60, 1851\u20131861 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFni3457_CR12","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/art.24570","volume":"60","author":"D Marek-Yagel","year":"2009","unstructured":"Marek-Yagel, D. et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 60, 1862\u20131866 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFni3457_CR13","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/art.24565","volume":"60","author":"S Ozen","year":"2009","unstructured":"Ozen, S. Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation? Arthritis Rheum. 60, 1575\u20131577 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFni3457_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/qjmed\/93.4.217","volume":"93","author":"DR Booth","year":"2000","unstructured":"Booth, D.R. et al. The genetic basis of autosomal dominant familial Mediterranean fever. Q. J. Med. 93, 217\u2013221 (2000).","journal-title":"Q. J. Med."},{"key":"BFni3457_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ajmg.a.20296","volume":"124A","author":"A Aldea","year":"2004","unstructured":"Aldea, A. et al. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder? Am. J. Med. Genet. 124A, 67\u201373 (2004).","journal-title":"Am. J. Med. Genet."},{"key":"BFni3457_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature05286","volume":"444","author":"JD Jones","year":"2006","unstructured":"Jones, J.D. & Dangl, J.L. The plant immune system. Nature 444, 323\u2013329 (2006).","journal-title":"Nature"},{"key":"BFni3457_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0092-8674(02)00661-X","volume":"108","author":"D Mackey","year":"2002","unstructured":"Mackey, D., Holt, B.F. III, Wiig, A. & Dangl, J.L. RIN4 interacts with Pseudomonas syringae type III effector molecules and is required for RPM1-mediated resistance in Arabidopsis. Cell 108, 743\u2013754 (2002).","journal-title":"Cell"},{"key":"BFni3457_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1097-2765(03)00056-X","volume":"11","author":"JJ Chae","year":"2003","unstructured":"Chae, J.J. et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol. Cell 11, 591\u2013604 (2003).","journal-title":"Mol. Cell"},{"key":"BFni3457_CR19","doi-asserted-by":"publisher","first-page":"14359","DOI":"10.1074\/jbc.274.20.14359","volume":"274","author":"SM Schoenwaelder","year":"1999","unstructured":"Schoenwaelder, S.M. & Burridge, K. Evidence for a calpeptin-sensitive protein-tyrosine phosphatase upstream of the small GTPase Rho: a novel role for the calpain inhibitor calpeptin in the inhibition of protein-tyrosine phosphatases. J. Biol. Chem. 274, 14359\u201314367 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFni3457_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/42735","volume":"387","author":"G Schmidt","year":"1997","unstructured":"Schmidt, G. et al. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387, 725\u2013729 (1997).","journal-title":"Nature"},{"key":"BFni3457_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/42743","volume":"387","author":"G Flatau","year":"1997","unstructured":"Flatau, G. et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387, 729\u2013733 (1997).","journal-title":"Nature"},{"key":"BFni3457_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature11588","volume":"492","author":"GS Lee","year":"2012","unstructured":"Lee, G.S. et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492, 123\u2013127 (2012).","journal-title":"Nature"},{"key":"BFni3457_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/j.1460-2075.1996.tb00383.x","volume":"15","author":"P Lang","year":"1996","unstructured":"Lang, P. et al. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 15, 510\u2013519 (1996).","journal-title":"EMBO J."},{"key":"BFni3457_CR24","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1182\/blood-2013-03-487850","volume":"122","author":"A Aburima","year":"2013","unstructured":"Aburima, A. et al. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway. Blood 122, 3533\u20133545 (2013).","journal-title":"Blood"},{"key":"BFni3457_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ncb773","volume":"4","author":"M Krendel","year":"2002","unstructured":"Krendel, M., Zenke, F.T. & Bokoch, G.M. Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton. Nat. Cell Biol. 4, 294\u2013301 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFni3457_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa, T. et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 14, 454\u2013460 (2013).","journal-title":"Nat. Immunol."},{"key":"BFni3457_CR27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.15252\/embr.201438463","volume":"15","author":"R Allam","year":"2014","unstructured":"Allam, R. et al. Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming. EMBO Rep. 15, 982\u2013990 (2014).","journal-title":"EMBO Rep."},{"key":"BFni3457_CR28","doi-asserted-by":"publisher","first-page":"e00097","DOI":"10.1042\/BSR20140010","volume":"34","author":"MD Falk","year":"2014","unstructured":"Falk, M.D. et al. Enzyme kinetics and distinct modulation of the protein kinase N Family of kinases by lipid activators and small molecule inhibitors. Biosci. Rep. 34, e00097 (2014).","journal-title":"Biosci. Rep."},{"key":"BFni3457_CR29","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1074\/jbc.274.6.3744","volume":"274","author":"J Feng","year":"1999","unstructured":"Feng, J. et al. Rho-associated kinase of chicken gizzard smooth muscle. J. Biol. Chem. 274, 3744\u20133752 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFni3457_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a022476","volume":"126","author":"C Yoshinaga","year":"1999","unstructured":"Yoshinaga, C., Mukai, H., Toshimori, M., Miyamoto, M. & Ono, Y. Mutational analysis of the regulatory mechanism of PKN: the regulatory region of PKN contains an arachidonic acid-sensitive autoinhibitory domain. J. Biochem. 126, 475\u2013484 (1999).","journal-title":"J. Biochem."},{"key":"BFni3457_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lfs.2003.09.031","volume":"74","author":"JW Regan","year":"2003","unstructured":"Regan, J.W. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74, 143\u2013153 (2003).","journal-title":"Life Sci."},{"key":"BFni3457_CR32","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.4049\/jimmunol.1401343","volume":"194","author":"M Sokolowska","year":"2015","unstructured":"Sokolowska, M. et al. Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J. Immunol. 194, 5472\u20135487 (2015).","journal-title":"J. Immunol."},{"key":"BFni3457_CR33","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/art.21050","volume":"52","author":"I J\u00e9ru","year":"2005","unstructured":"J\u00e9ru, I. et al. Interaction of pyrin with 14.3.3 in an isoform-specific and phosphorylation-dependent manner regulates its translocation to the nucleus. Arthritis Rheum. 52, 1848\u20131857 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFni3457_CR34","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1002\/art.22194","volume":"54","author":"SH Mandey","year":"2006","unstructured":"Mandey, S.H., Kuijk, L.M., Frenkel, J. & Waterham, H.R. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum. 54, 3690\u20133695 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFni3457_CR35","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1182\/blood-2008-03-144667","volume":"112","author":"LM Kuijk","year":"2008","unstructured":"Kuijk, L.M. et al. HMG-CoA reductase inhibition induces IL-1beta release through Rac1\/PI3K\/PKB-dependent caspase-1 activation. Blood 112, 3563\u20133573 (2008).","journal-title":"Blood"},{"key":"BFni3457_CR36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1684\/ecn.2009.0163","volume":"20","author":"S Normand","year":"2009","unstructured":"Normand, S. et al. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation. Eur. Cytokine Netw. 20, 101\u2013107 (2009).","journal-title":"Eur. Cytokine Netw."},{"key":"BFni3457_CR37","doi-asserted-by":"publisher","first-page":"332ra45","DOI":"10.1126\/scitranslmed.aaf1471","volume":"8","author":"SL Masters","year":"2016","unstructured":"Masters, S.L. et al. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Sci. Transl. Med. 8, 332ra45 (2016).","journal-title":"Sci. Transl. Med."},{"key":"BFni3457_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10875-010-9389-2","volume":"30","author":"RE Vance","year":"2010","unstructured":"Vance, R.E. Immunology taught by bacteria. J. Clin. Immunol. 30, 507\u2013511 (2010).","journal-title":"J. Clin. Immunol."},{"key":"BFni3457_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/10408410490468795","volume":"30","author":"N Ahuja","year":"2004","unstructured":"Ahuja, N., Kumar, P. & Bhatnagar, R. The adenylate cyclase toxins. Crit. Rev. Microbiol. 30, 187\u2013196 (2004).","journal-title":"Crit. Rev. Microbiol."},{"key":"BFni3457_CR40","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.1073\/pnas.0602081103","volume":"103","author":"JJ Chae","year":"2006","unstructured":"Chae, J.J. et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc. Natl. Acad. Sci. USA 103, 9982\u20139987 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni.3457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.3457","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.3457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:10:55Z","timestamp":1684433455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni.3457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,6]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFni3457"],"URL":"https:\/\/doi.org\/10.1038\/ni.3457","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,6]]},"assertion":[{"value":"11 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}